1215 related articles for article (PubMed ID: 17283584)
1. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
3. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
10. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
11. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity.
Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB
Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236
[TBL] [Abstract][Full Text] [Related]
12. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
Harris EN; Pierangeli SS
Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
[TBL] [Abstract][Full Text] [Related]
13. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
14. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
18. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
19. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]